Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-28 Purchase |
2021-06-30 6:09 pm |
Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:08 pm |
Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:08 pm |
Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:07 pm |
Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:06 pm |
Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:06 pm |
Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:05 pm |
Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:04 pm |
Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:02 pm |
Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:02 pm |
Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:01 pm |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:00 pm |
Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-14 Option Award |
2023-06-15 4:26 pm |
N/A 2033-06-13 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-03-30 Option Award |
2023-03-31 4:15 pm |
N/A 2033-03-29 |
Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO |
472,000 | $0 | 472,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel |
123,650 | $0 | 123,650 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
78,550 | $0 | 78,550 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:30 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer |
77,450 | $0 | 77,450 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:30 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist |
78,500 | $0 | 78,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:30 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer |
129,850 | $0 | 129,850 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:30 pm |
N/A 2033-01-02 |
Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:42 pm |
N/A 2032-10-02 |
Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer |
36,000 | $0 | 36,000 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-01 4:30 pm |
N/A 2032-10-02 |
Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer |
36,000 | $0 | 36,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:29 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:32 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:31 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:30 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:49 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer |
73,300 | $0 | 73,300 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:47 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer |
111,700 | $0 | 111,700 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:46 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer |
86,500 | $0 | 86,500 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:46 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:43 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel |
70,600 | $0 | 70,600 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:42 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist |
53,700 | $0 | 53,700 (Direct) |
View |
Ownership |
2022-03-02 6:39 pm |
N/A 2031-05-16 |
Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel |
0 | $0 | 116,120 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:32 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer |
117,450 | $0 | 117,450 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:26 pm |
N/A 2032-02-29 |
Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO |
315,600 | $0 | 315,600 (Direct) |
View |
Ownership |
2021-12-02 6:12 pm |
N/A 2030-08-31 |
Monte Rosa Therapeutics Inc. | GLUE | Jones Julian G Chief Business Officer |
0 | $0 | 251,594 (Direct) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:09 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Yang Rick 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:08 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Walker Paul Edward 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:08 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Sonsini Peter W. 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:07 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | SANDELL SCOTT D 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:06 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:06 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | MAKOWER JOSHUA 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:05 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Makhzoumi Mohamad 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:04 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Landsman Liza 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:02 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Florence Anthony A. Jr. 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:02 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Chang Carmen 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:01 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | BASKETT FOREST 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |